Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO4720 | Aglaia perviridis | Species | Meliaceae | Eukaryota | leaves, twigs, and fruits | Nui Chua National Park (11° 43' N; 109° 08' E; 730 m alt.), Ninh Thuan Province, Vietnam | 2010-JAN |
PMID[23301897] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 10 | nM | 16643044 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 10 | nM | 21131198 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 10 | nM | 20598881 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 10 | nM | DrugMatrix in vitro pharmacology data | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 10 | nM | DrugMatrix in vivo data: Hematology | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 10 | nM | 26295746 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 10 | nM | 22472691 | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 65.61 | nM | 23131412 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 10 | nM | 18280170 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 10 | nM | 23102654 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 10 | nM | 8254344 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 14.22 | nM | 10479316 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 10 | nM | 24079846 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 10 | nM | DrugMatrix in vitro pharmacology data | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 10 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 10.62 | nM | Open TG-GATES in vivo data: Hematology | |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | ED50 | > | 20 | nM | Open TG-GATES in vivo data: Hematology |
NPT2 | Others | Unspecified | ED50 | > | 50 | nM | 15646539 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 10.64 | nM | 21980963 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 10.76 | nM | 20605448 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 10 | nM | 22771007 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 10 | nM | 12608855 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 11.22 | nM | 18077363 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 10 | nM | 17154505 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 10 | nM | 10.6019/CHEMBL1201861 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 10 | nM | 18341287 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 10 | nM | 25856683 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 16.18 | nM | 23268694 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 12.59 | nM | 22194678 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 19.23 | nM | 15679308 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 10 | nM | 17502410 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 10 | nM | DrugMatrix in vitro pharmacology data | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 10 | nM | 17172311 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | ED50 | = | 0.021 | nM | 17850214 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 10 | nM | DrugMatrix in vitro pharmacology data | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 10 | nM | 23252848 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 10 | nM | 18442909 | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 10 | nM | 17938185 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 10 | nM | 20100877 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 10.21 | nM | 18973387 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 10 | nM | 24775915 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 10 | nM | 19860383 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 10 | nM | 19746919 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 10 | nM | 18771242 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 10 | nM | 23145884 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 16.41 | nM | 8864236 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 16.11 | nM | 26327273 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 10.5 | nM | 19309154 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 10 | nM | 17954687 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 10 | nM | 20000576 | |
NPT2 | Others | Unspecified | IC50 | = | 44 | nM | 20231390 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 10 | nM | 19487447 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 10 | nM | Open TG-GATES in vivo data: Hematology | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 10 | nM | DrugMatrix in vivo data: Hematology | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 10 | nM | 26046820 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 10 | nM | 16643032 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 10 | nM | 19318257 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 10 | nM | 17284598 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 10 | nM | 2292689 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC51543 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.966 | High Similarity | NPC87363 |
0.9375 | High Similarity | NPC184607 |
0.9306 | High Similarity | NPC470937 |
0.8993 | High Similarity | NPC20360 |
0.8974 | High Similarity | NPC470936 |
0.8599 | High Similarity | NPC189730 |
0.8535 | High Similarity | NPC164152 |
0.8438 | Intermediate Similarity | NPC73422 |
0.8438 | Intermediate Similarity | NPC310399 |
0.8389 | Intermediate Similarity | NPC474687 |
0.8375 | Intermediate Similarity | NPC329743 |
0.8375 | Intermediate Similarity | NPC209473 |
0.8356 | Intermediate Similarity | NPC162801 |
0.8333 | Intermediate Similarity | NPC475836 |
0.8322 | Intermediate Similarity | NPC3049 |
0.8311 | Intermediate Similarity | NPC117048 |
0.8311 | Intermediate Similarity | NPC124085 |
0.8272 | Intermediate Similarity | NPC90336 |
0.8243 | Intermediate Similarity | NPC85435 |
0.82 | Intermediate Similarity | NPC262585 |
0.82 | Intermediate Similarity | NPC18189 |
0.82 | Intermediate Similarity | NPC20829 |
0.8194 | Intermediate Similarity | NPC324492 |
0.8194 | Intermediate Similarity | NPC211758 |
0.8194 | Intermediate Similarity | NPC317053 |
0.8194 | Intermediate Similarity | NPC87794 |
0.8182 | Intermediate Similarity | NPC475621 |
0.8176 | Intermediate Similarity | NPC13005 |
0.8151 | Intermediate Similarity | NPC87224 |
0.8151 | Intermediate Similarity | NPC39064 |
0.8151 | Intermediate Similarity | NPC47283 |
0.8151 | Intermediate Similarity | NPC222572 |
0.8141 | Intermediate Similarity | NPC328567 |
0.8141 | Intermediate Similarity | NPC327412 |
0.8141 | Intermediate Similarity | NPC320970 |
0.8141 | Intermediate Similarity | NPC320671 |
0.8129 | Intermediate Similarity | NPC181615 |
0.8118 | Intermediate Similarity | NPC206061 |
0.8117 | Intermediate Similarity | NPC274721 |
0.8117 | Intermediate Similarity | NPC135767 |
0.8117 | Intermediate Similarity | NPC155392 |
0.8108 | Intermediate Similarity | NPC280653 |
0.8108 | Intermediate Similarity | NPC476166 |
0.8108 | Intermediate Similarity | NPC164574 |
0.8108 | Intermediate Similarity | NPC103799 |
0.8108 | Intermediate Similarity | NPC17343 |
0.8108 | Intermediate Similarity | NPC206224 |
0.8108 | Intermediate Similarity | NPC12875 |
0.8108 | Intermediate Similarity | NPC150011 |
0.8108 | Intermediate Similarity | NPC118114 |
0.8108 | Intermediate Similarity | NPC196765 |
0.8108 | Intermediate Similarity | NPC207892 |
0.8108 | Intermediate Similarity | NPC129784 |
0.8108 | Intermediate Similarity | NPC129106 |
0.8108 | Intermediate Similarity | NPC236014 |
0.8108 | Intermediate Similarity | NPC268917 |
0.8108 | Intermediate Similarity | NPC300875 |
0.8108 | Intermediate Similarity | NPC228369 |
0.8105 | Intermediate Similarity | NPC476334 |
0.8077 | Intermediate Similarity | NPC260397 |
0.8067 | Intermediate Similarity | NPC115335 |
0.8067 | Intermediate Similarity | NPC225696 |
0.8067 | Intermediate Similarity | NPC296915 |
0.8067 | Intermediate Similarity | NPC97834 |
0.8067 | Intermediate Similarity | NPC223008 |
0.8067 | Intermediate Similarity | NPC198154 |
0.8065 | Intermediate Similarity | NPC277951 |
0.8065 | Intermediate Similarity | NPC114119 |
0.8065 | Intermediate Similarity | NPC317237 |
0.8065 | Intermediate Similarity | NPC470097 |
0.8065 | Intermediate Similarity | NPC471415 |
0.8065 | Intermediate Similarity | NPC44530 |
0.8041 | Intermediate Similarity | NPC470225 |
0.8041 | Intermediate Similarity | NPC27187 |
0.8039 | Intermediate Similarity | NPC184797 |
0.8039 | Intermediate Similarity | NPC309124 |
0.8026 | Intermediate Similarity | NPC477938 |
0.8014 | Intermediate Similarity | NPC262573 |
0.8014 | Intermediate Similarity | NPC50315 |
0.8014 | Intermediate Similarity | NPC471215 |
0.8014 | Intermediate Similarity | NPC26879 |
0.8014 | Intermediate Similarity | NPC283049 |
0.8014 | Intermediate Similarity | NPC230479 |
0.8 | Intermediate Similarity | NPC215037 |
0.8 | Intermediate Similarity | NPC294156 |
0.8 | Intermediate Similarity | NPC256015 |
0.8 | Intermediate Similarity | NPC92805 |
0.7988 | Intermediate Similarity | NPC149502 |
0.7988 | Intermediate Similarity | NPC222665 |
0.7988 | Intermediate Similarity | NPC271755 |
0.7988 | Intermediate Similarity | NPC254071 |
0.7987 | Intermediate Similarity | NPC108674 |
0.7987 | Intermediate Similarity | NPC271945 |
0.7987 | Intermediate Similarity | NPC178054 |
0.7987 | Intermediate Similarity | NPC277331 |
0.7987 | Intermediate Similarity | NPC100482 |
0.7987 | Intermediate Similarity | NPC181497 |
0.7987 | Intermediate Similarity | NPC263261 |
0.7987 | Intermediate Similarity | NPC87725 |
0.7974 | Intermediate Similarity | NPC232164 |
0.7974 | Intermediate Similarity | NPC473739 |
0.7974 | Intermediate Similarity | NPC236306 |
0.7961 | Intermediate Similarity | NPC126101 |
0.7961 | Intermediate Similarity | NPC327735 |
0.7961 | Intermediate Similarity | NPC141717 |
0.7949 | Intermediate Similarity | NPC475492 |
0.7945 | Intermediate Similarity | NPC207179 |
0.7945 | Intermediate Similarity | NPC167571 |
0.7945 | Intermediate Similarity | NPC278552 |
0.7937 | Intermediate Similarity | NPC324517 |
0.7937 | Intermediate Similarity | NPC329343 |
0.7937 | Intermediate Similarity | NPC321972 |
0.7935 | Intermediate Similarity | NPC107161 |
0.7935 | Intermediate Similarity | NPC472353 |
0.7931 | Intermediate Similarity | NPC474160 |
0.7922 | Intermediate Similarity | NPC254759 |
0.7922 | Intermediate Similarity | NPC174787 |
0.7922 | Intermediate Similarity | NPC182509 |
0.7922 | Intermediate Similarity | NPC291101 |
0.7922 | Intermediate Similarity | NPC160283 |
0.7922 | Intermediate Similarity | NPC27495 |
0.7922 | Intermediate Similarity | NPC266197 |
0.7922 | Intermediate Similarity | NPC213607 |
0.7905 | Intermediate Similarity | NPC274717 |
0.7905 | Intermediate Similarity | NPC53986 |
0.7905 | Intermediate Similarity | NPC38664 |
0.7895 | Intermediate Similarity | NPC11727 |
0.7895 | Intermediate Similarity | NPC125579 |
0.7895 | Intermediate Similarity | NPC164787 |
0.7895 | Intermediate Similarity | NPC15109 |
0.7895 | Intermediate Similarity | NPC151224 |
0.7895 | Intermediate Similarity | NPC61946 |
0.7885 | Intermediate Similarity | NPC173203 |
0.7885 | Intermediate Similarity | NPC163508 |
0.7885 | Intermediate Similarity | NPC477616 |
0.7881 | Intermediate Similarity | NPC263064 |
0.7871 | Intermediate Similarity | NPC471389 |
0.7871 | Intermediate Similarity | NPC5155 |
0.7871 | Intermediate Similarity | NPC311530 |
0.7871 | Intermediate Similarity | NPC247291 |
0.7867 | Intermediate Similarity | NPC211413 |
0.7867 | Intermediate Similarity | NPC164804 |
0.7867 | Intermediate Similarity | NPC244888 |
0.7867 | Intermediate Similarity | NPC293203 |
0.7867 | Intermediate Similarity | NPC68205 |
0.7867 | Intermediate Similarity | NPC472590 |
0.7867 | Intermediate Similarity | NPC118683 |
0.7862 | Intermediate Similarity | NPC20757 |
0.7862 | Intermediate Similarity | NPC329836 |
0.7862 | Intermediate Similarity | NPC227516 |
0.7857 | Intermediate Similarity | NPC22517 |
0.7857 | Intermediate Similarity | NPC471388 |
0.7857 | Intermediate Similarity | NPC292882 |
0.7852 | Intermediate Similarity | NPC93962 |
0.7849 | Intermediate Similarity | NPC23593 |
0.7843 | Intermediate Similarity | NPC306441 |
0.7843 | Intermediate Similarity | NPC302701 |
0.7843 | Intermediate Similarity | NPC248727 |
0.7843 | Intermediate Similarity | NPC162659 |
0.7843 | Intermediate Similarity | NPC270456 |
0.7843 | Intermediate Similarity | NPC16435 |
0.7843 | Intermediate Similarity | NPC265433 |
0.7843 | Intermediate Similarity | NPC227503 |
0.7843 | Intermediate Similarity | NPC230734 |
0.7843 | Intermediate Similarity | NPC474639 |
0.7843 | Intermediate Similarity | NPC269091 |
0.7834 | Intermediate Similarity | NPC12641 |
0.7834 | Intermediate Similarity | NPC15659 |
0.7834 | Intermediate Similarity | NPC45257 |
0.7834 | Intermediate Similarity | NPC280092 |
0.7834 | Intermediate Similarity | NPC93323 |
0.7834 | Intermediate Similarity | NPC304894 |
0.7829 | Intermediate Similarity | NPC476617 |
0.7829 | Intermediate Similarity | NPC476615 |
0.7829 | Intermediate Similarity | NPC287745 |
0.7829 | Intermediate Similarity | NPC476616 |
0.7823 | Intermediate Similarity | NPC81641 |
0.7812 | Intermediate Similarity | NPC470098 |
0.7812 | Intermediate Similarity | NPC473266 |
0.7812 | Intermediate Similarity | NPC470826 |
0.7808 | Intermediate Similarity | NPC76465 |
0.7808 | Intermediate Similarity | NPC38761 |
0.7806 | Intermediate Similarity | NPC22317 |
0.7799 | Intermediate Similarity | NPC101376 |
0.7799 | Intermediate Similarity | NPC21776 |
0.7799 | Intermediate Similarity | NPC16269 |
0.7792 | Intermediate Similarity | NPC94994 |
0.7791 | Intermediate Similarity | NPC107739 |
0.7785 | Intermediate Similarity | NPC469557 |
0.7778 | Intermediate Similarity | NPC93783 |
0.7778 | Intermediate Similarity | NPC260898 |
0.7778 | Intermediate Similarity | NPC474206 |
0.7778 | Intermediate Similarity | NPC234333 |
0.7778 | Intermediate Similarity | NPC470356 |
0.7778 | Intermediate Similarity | NPC121812 |
0.7778 | Intermediate Similarity | NPC112246 |
0.7778 | Intermediate Similarity | NPC47398 |
0.7778 | Intermediate Similarity | NPC112939 |
0.7778 | Intermediate Similarity | NPC99572 |
0.7778 | Intermediate Similarity | NPC94750 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC51543 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8027 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7919 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7697 | Intermediate Similarity | NPD1613 | Approved |
0.7697 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7671 | Intermediate Similarity | NPD1610 | Phase 2 |
0.76 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7582 | Intermediate Similarity | NPD5837 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD5735 | Approved |
0.7515 | Intermediate Similarity | NPD7199 | Phase 2 |
0.75 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7484 | Intermediate Similarity | NPD7466 | Approved |
0.7455 | Intermediate Similarity | NPD6072 | Discontinued |
0.7434 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7372 | Intermediate Similarity | NPD2157 | Approved |
0.7368 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7349 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7346 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7346 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7326 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7301 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7296 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7296 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7296 | Intermediate Similarity | NPD5762 | Approved |
0.7296 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7296 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7296 | Intermediate Similarity | NPD5763 | Approved |
0.7296 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD4097 | Suspended |
0.7235 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7226 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD4749 | Approved |
0.7195 | Intermediate Similarity | NPD7020 | Approved |
0.7195 | Intermediate Similarity | NPD7019 | Approved |
0.7161 | Intermediate Similarity | NPD4625 | Phase 3 |
0.716 | Intermediate Similarity | NPD3892 | Phase 2 |
0.716 | Intermediate Similarity | NPD6331 | Phase 2 |
0.716 | Intermediate Similarity | NPD7046 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6353 | Approved |
0.7143 | Intermediate Similarity | NPD2424 | Discontinued |
0.7124 | Intermediate Similarity | NPD3094 | Phase 2 |
0.7117 | Intermediate Similarity | NPD2677 | Approved |
0.7099 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD7446 | Clinical (unspecified phase) |
0.7089 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7089 | Intermediate Similarity | NPD6355 | Discontinued |
0.7089 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7086 | Intermediate Similarity | NPD1091 | Approved |
0.7076 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7076 | Intermediate Similarity | NPD4965 | Approved |
0.7076 | Intermediate Similarity | NPD4966 | Approved |
0.7073 | Intermediate Similarity | NPD5058 | Phase 3 |
0.707 | Intermediate Similarity | NPD7477 | Discontinued |
0.7063 | Intermediate Similarity | NPD5588 | Approved |
0.7059 | Intermediate Similarity | NPD8651 | Approved |
0.7044 | Intermediate Similarity | NPD6653 | Approved |
0.7025 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7025 | Intermediate Similarity | NPD4140 | Approved |
0.7025 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7025 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7019 | Intermediate Similarity | NPD2161 | Phase 2 |
0.7006 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD6798 | Discontinued |
0.7 | Intermediate Similarity | NPD37 | Approved |
0.7 | Intermediate Similarity | NPD4537 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD4536 | Approved |
0.7 | Intermediate Similarity | NPD4538 | Approved |
0.6994 | Remote Similarity | NPD1652 | Phase 2 |
0.6994 | Remote Similarity | NPD6234 | Discontinued |
0.6993 | Remote Similarity | NPD6582 | Phase 2 |
0.6993 | Remote Similarity | NPD5327 | Phase 3 |
0.6993 | Remote Similarity | NPD6583 | Phase 3 |
0.6988 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6988 | Remote Similarity | NPD3985 | Discontinued |
0.6986 | Remote Similarity | NPD821 | Approved |
0.6982 | Remote Similarity | NPD4675 | Approved |
0.6982 | Remote Similarity | NPD4678 | Approved |
0.697 | Remote Similarity | NPD3122 | Phase 3 |
0.6968 | Remote Similarity | NPD6584 | Phase 3 |
0.6962 | Remote Similarity | NPD3162 | Approved |
0.6962 | Remote Similarity | NPD1726 | Clinical (unspecified phase) |
0.6962 | Remote Similarity | NPD3163 | Approved |
0.6959 | Remote Similarity | NPD5929 | Approved |
0.6959 | Remote Similarity | NPD7157 | Approved |
0.6957 | Remote Similarity | NPD7033 | Discontinued |
0.6954 | Remote Similarity | NPD6516 | Phase 2 |
0.6954 | Remote Similarity | NPD5846 | Approved |
0.6946 | Remote Similarity | NPD7526 | Approved |
0.6946 | Remote Similarity | NPD5261 | Clinical (unspecified phase) |
0.6946 | Remote Similarity | NPD7527 | Clinical (unspecified phase) |
0.6946 | Remote Similarity | NPD52 | Approved |
0.6944 | Remote Similarity | NPD2684 | Approved |
0.6928 | Remote Similarity | NPD2231 | Phase 2 |
0.6928 | Remote Similarity | NPD2235 | Phase 2 |
0.6923 | Remote Similarity | NPD4005 | Discontinued |
0.6923 | Remote Similarity | NPD1712 | Approved |
0.6919 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD4060 | Phase 1 |
0.6918 | Remote Similarity | NPD3597 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD5712 | Approved |
0.6906 | Remote Similarity | NPD7549 | Discontinued |
0.6901 | Remote Similarity | NPD1934 | Approved |
0.6893 | Remote Similarity | NPD6166 | Phase 2 |
0.6893 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.6893 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.6882 | Remote Similarity | NPD4380 | Phase 2 |
0.6879 | Remote Similarity | NPD4868 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD290 | Approved |
0.6871 | Remote Similarity | NPD7843 | Approved |
0.6863 | Remote Similarity | NPD3092 | Approved |
0.686 | Remote Similarity | NPD2393 | Clinical (unspecified phase) |
0.6859 | Remote Similarity | NPD3690 | Phase 2 |
0.6859 | Remote Similarity | NPD3691 | Phase 2 |
0.6859 | Remote Similarity | NPD4624 | Approved |
0.6859 | Remote Similarity | NPD6917 | Clinical (unspecified phase) |
0.6857 | Remote Similarity | NPD6746 | Phase 2 |
0.6855 | Remote Similarity | NPD1423 | Approved |
0.6855 | Remote Similarity | NPD6233 | Phase 2 |
0.6852 | Remote Similarity | NPD3846 | Clinical (unspecified phase) |
0.6852 | Remote Similarity | NPD5960 | Phase 3 |
0.6839 | Remote Similarity | NPD6971 | Discontinued |
0.6839 | Remote Similarity | NPD4381 | Clinical (unspecified phase) |
0.6835 | Remote Similarity | NPD3180 | Approved |
0.6835 | Remote Similarity | NPD3179 | Approved |
0.6826 | Remote Similarity | NPD6087 | Phase 1 |
0.6821 | Remote Similarity | NPD7741 | Discontinued |
0.6821 | Remote Similarity | NPD2415 | Discontinued |
0.6816 | Remote Similarity | NPD7228 | Approved |
0.6796 | Remote Similarity | NPD7007 | Discovery |
0.6788 | Remote Similarity | NPD5062 | Approved |
0.6788 | Remote Similarity | NPD5061 | Approved |
0.6788 | Remote Similarity | NPD6674 | Discontinued |
0.6786 | Remote Similarity | NPD4378 | Clinical (unspecified phase) |
0.6786 | Remote Similarity | NPD681 | Clinical (unspecified phase) |
0.678 | Remote Similarity | NPD7229 | Phase 3 |
0.6778 | Remote Similarity | NPD5844 | Phase 1 |
0.6774 | Remote Similarity | NPD3685 | Discontinued |
0.6768 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD2029 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6766 | Remote Similarity | NPD6667 | Approved |
0.6766 | Remote Similarity | NPD6815 | Approved |
0.6766 | Remote Similarity | NPD6666 | Approved |
0.6763 | Remote Similarity | NPD5772 | Approved |
0.6763 | Remote Similarity | NPD8455 | Phase 2 |
0.6763 | Remote Similarity | NPD5773 | Approved |
0.6763 | Remote Similarity | NPD5761 | Phase 2 |
0.6763 | Remote Similarity | NPD5760 | Phase 2 |
0.6763 | Remote Similarity | NPD7096 | Clinical (unspecified phase) |
0.6758 | Remote Similarity | NPD6559 | Discontinued |
0.6753 | Remote Similarity | NPD422 | Phase 1 |
0.675 | Remote Similarity | NPD840 | Approved |
0.675 | Remote Similarity | NPD839 | Approved |
0.6748 | Remote Similarity | NPD2155 | Approved |
0.6748 | Remote Similarity | NPD2156 | Approved |
0.6748 | Remote Similarity | NPD2154 | Approved |
0.6747 | Remote Similarity | NPD4628 | Phase 3 |
0.6746 | Remote Similarity | NPD7314 | Clinical (unspecified phase) |
0.6744 | Remote Similarity | NPD3778 | Approved |
0.6743 | Remote Similarity | NPD7075 | Discontinued |
0.673 | Remote Similarity | NPD7095 | Approved |
0.673 | Remote Similarity | NPD6179 | Discontinued |
0.6728 | Remote Similarity | NPD1772 | Clinical (unspecified phase) |
0.6728 | Remote Similarity | NPD3054 | Approved |
0.6728 | Remote Similarity | NPD3052 | Approved |
0.6727 | Remote Similarity | NPD1549 | Phase 2 |
0.6727 | Remote Similarity | NPD7037 | Approved |
0.6726 | Remote Similarity | NPD4357 | Discontinued |
0.6725 | Remote Similarity | NPD6523 | Clinical (unspecified phase) |
0.6725 | Remote Similarity | NPD8158 | Clinical (unspecified phase) |
0.6722 | Remote Similarity | NPD3818 | Discontinued |
0.6711 | Remote Similarity | NPD6580 | Approved |
0.6711 | Remote Similarity | NPD6581 | Approved |
0.6709 | Remote Similarity | NPD3018 | Phase 2 |
0.6707 | Remote Similarity | NPD2796 | Approved |
0.6707 | Remote Similarity | NPD6100 | Approved |
0.6707 | Remote Similarity | NPD6099 | Approved |
0.6707 | Remote Similarity | NPD5307 | Clinical (unspecified phase) |
0.6705 | Remote Similarity | NPD6801 | Discontinued |
0.6688 | Remote Similarity | NPD6362 | Approved |
0.6687 | Remote Similarity | NPD1048 | Approved |
0.6687 | Remote Similarity | NPD5177 | Phase 3 |
0.6687 | Remote Similarity | NPD7097 | Phase 1 |
0.6687 | Remote Similarity | NPD2200 | Suspended |
0.6686 | Remote Similarity | NPD4581 | Clinical (unspecified phase) |
0.6686 | Remote Similarity | NPD3536 | Discontinued |
0.6686 | Remote Similarity | NPD7773 | Phase 2 |
0.6686 | Remote Similarity | NPD3882 | Suspended |
0.6686 | Remote Similarity | NPD4123 | Phase 3 |
0.6686 | Remote Similarity | NPD6502 | Phase 2 |
0.6686 | Remote Similarity | NPD7768 | Phase 2 |
0.6686 | Remote Similarity | NPD7410 | Clinical (unspecified phase) |
0.6685 | Remote Similarity | NPD3051 | Approved |
0.6667 | Remote Similarity | NPD1375 | Discontinued |
0.6667 | Remote Similarity | NPD4666 | Phase 3 |
0.6667 | Remote Similarity | NPD2801 | Approved |
0.6667 | Remote Similarity | NPD5494 | Approved |
0.6667 | Remote Similarity | NPD6830 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1653 | Approved |
PubChem CID   | 397614 |
ChEMBL   | CHEMBL583207 |
ZINC   |
Molecular Weight:   | 477.18 |
ALogP:   | -2.2075 |
MLogP:   | 3.55 |
XLogP:   | 5.481 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 121.46 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 4 |
# Rings:   | 5 |
# Heavy Atoms:   | 35 |